Starcast
Join the waitlist
Why Peptides Could Become More Accessible in the U.S.
Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.
On this episode
About this episode
P.M. Edition for July 24. Today an FDA committee voted to increase access to six of seven peptides. Those are substances that haven’t undergone regulatory approval, but they’re promoted on social media and promise physical transformations like better skin. We hear from WSJ health and wellness reporter Alex Janin about what the vote means and whether it paves the way for a peptide gold rush. Plus, new tariffs went into effect today intended to combat forced labor, and President Trump also threatened new tariffs on the European Union. Journal trade and economic policy reporter Gavin Bade discusses the future of President Trump’s tariff agenda. And measles cases in the U.S. this year have…